financetom
Business
financetom
/
Business
/
AstraZeneca 2025 sales outlook tops expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AstraZeneca 2025 sales outlook tops expectations
Feb 5, 2025 11:36 PM

Feb 6 (Reuters) - AstraZeneca ( AZN ) forecast its 2025

sales above analysts' expectations on Thursday, after the

drugmaker's fourth-quarter revenue beat estimates, driven by

robust demand, especially for its medicines for cancer and heart

diseases.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved